NEW YORK, Dec. 17 - Avalon Pharmaceuticals has closed a Series B private equity round worth $70 million that it will use to expand the development of its genomics-based drug-screening approach, the company said on Monday.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.
The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.
The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.
Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."